{
  "docId": "019de072-732a-71e9-b112-1e6d82feb5fe",
  "docSlug": "6e830fd1eff0b0016042e74410778900",
  "documentTitle": "Alkermes | Results Presentation Deck | 16 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 16,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 26,
  "notes": "The chart highlights holiday weeks with double asterisks.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-732a-71e9-b112-1e6d82feb5fe/11",
  "deckHref": "/decks/019de072-732a-71e9-b112-1e6d82feb5fe",
  "deckJsonHref": "/decks/019de072-732a-71e9-b112-1e6d82feb5fe.json",
  "deckAnchorHref": "/decks/019de072-732a-71e9-b112-1e6d82feb5fe#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.65,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Post-Launch TRx by Week",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0bd4a554-7967-49a1-927f-c4d253d534e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.2,
        "x": 0.75,
        "y": 0.3
      },
      "kind": "list",
      "text": "Q1'22 total TRx: ~10,400. Since launch, ~2,650 prescribers had written a prescription for LYBALVI, supported by a competitive share of voice in the market and growing awareness levels among prescribers.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4f8406eb-223b-4496-8d2a-6b0b64db5334",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.15,
        "x": 0.05,
        "y": 0.83
      },
      "kind": "source-note",
      "text": "*Source: IQVIA NPA Weekly",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05054668-1ee4-4dfd-8522-23b6d90f92b1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "LYBALVI® Prescription Growth Trends",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bfc53e50-2f54-4282-a677-7cff709b27ba",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Data-Ink Ratio",
      "slug": "data-ink-ratio",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "1c4a8417-0d71-455b-a33f-672ffc38b2e4",
      "evidence": "The line chart has a clear and simple design, suggesting a high data-ink ratio.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 4,
      "beatId": "2ed6b697-8ca9-4fda-8682-8280cc707d55",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Financial and Product Overview",
      "beatSlug": null,
      "evidence": "Detailed financial and product performance metrics",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}